Medpace Holdings (MEDP) Other Non-Current Liabilities (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Other Non-Current Liabilities came in at $59.6 million in Q2 2026, up 14.77% YoY from $51.9 million in Q2 2025, and down 0.87% on a QoQ basis from $60.1 million in Q1 2026.
Medpace Holdings (MEDP) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Other Non-Current Liabilities data on file, last reported at $59.6 million in Q2 2026.
- Quarterly Other Non-Current Liabilities rose 14.77% year-over-year to $59.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $59.6 million (up 14.77% YoY) and the FY2025 annual result came in at $57.7 million, up 34.92% from the prior year.
- Other Non-Current Liabilities retreated to $59.6 million in Q2 2026, from $60.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $60.1 million in Q1 2026 to a low of $17.2 million in Q1 2022.
- A 5-year average of $35.6 million and a median of $29.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities increased 6.93% — and 2025, when it soared 82.07%.
- Tracing MEDP's Other Non-Current Liabilities over 5 years: stood at $22.7 million in 2022, then gained by 24.32% to $28.2 million in 2023, then jumped by 51.43% to $42.7 million in 2024, then soared by 34.92% to $57.7 million in 2025, then advanced by 3.35% to $59.6 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $59.6 million (Q2 2026), $60.1 million (Q1 2026), and $57.7 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Medpace Holdings | 16.56 Bn | 16.06 Bn | 201.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.58 Mn |
| Mar 31, 2026 | 60.10 Mn |
| Dec 31, 2025 | 57.66 Mn |
| Sep 30, 2025 | 54.49 Mn |
| Jun 30, 2025 | 51.92 Mn |
| Mar 31, 2025 | 52.95 Mn |
| Dec 31, 2024 | 42.73 Mn |
| Sep 30, 2024 | 30.70 Mn |
| Jun 30, 2024 | 29.27 Mn |
| Mar 31, 2024 | 29.08 Mn |
| Dec 31, 2023 | 28.22 Mn |
| Sep 30, 2023 | 23.12 Mn |
| Jun 30, 2023 | 22.95 Mn |
| Mar 31, 2023 | 22.79 Mn |
| Dec 31, 2022 | 22.70 Mn |
| Sep 30, 2022 | 17.56 Mn |
| Jun 30, 2022 | 17.26 Mn |
| Mar 31, 2022 | 17.22 Mn |
| Dec 31, 2021 | 17.75 Mn |
| Sep 30, 2021 | 16.06 Mn |